<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Ment Health</journal-id><journal-id journal-id-type="iso-abbrev">Nat Ment Health</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Nature. Mental health</journal-title></journal-title-group><issn pub-type="epub">2731-6076</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11671152</article-id><article-id pub-id-type="pmcid-ver">PMC11671152.1</article-id><article-id pub-id-type="pmcaid">11671152</article-id><article-id pub-id-type="pmcaiid">11671152</article-id><article-id pub-id-type="manuscript-id">NIHMS2002970</article-id><article-id pub-id-type="pmid">39726823</article-id><article-id pub-id-type="doi">10.1038/s44220-024-00270-w</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2002970</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2002970</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Prescription psychostimulant use, admissions and treatment initiation and retention in pregnant people with opioid use disorder</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6595-695X</contrib-id><name name-style="western"><surname>Xu</surname><given-names initials="KY">Kevin Y.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A8" ref-type="aff">8</xref><xref rid="CR1" ref-type="corresp">&#9993;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berkel</surname><given-names initials="TDM">Tiffani D. M.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5560-458X</contrib-id><name name-style="western"><surname>Martin</surname><given-names initials="CE">Caitlin E.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jones</surname><given-names initials="HE">Hendr&#233;e E.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carter</surname><given-names initials="EB">Ebony B.</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kelly</surname><given-names initials="JC">Jeannie C.</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mintz</surname><given-names initials="CM">Carrie M.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Levin</surname><given-names initials="FR">Frances R.</given-names></name><xref rid="A5" ref-type="aff">5</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grucza</surname><given-names initials="RA">Richard A.</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.</aff><aff id="A2"><label>2</label>Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.</aff><aff id="A3"><label>3</label>Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.</aff><aff id="A4"><label>4</label>Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA.</aff><aff id="A5"><label>5</label>Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.</aff><aff id="A6"><label>6</label>Division of Substance Use Disorders, New York State Psychiatric Institute, New York, NY, USA.</aff><aff id="A7"><label>7</label>Department of Family/Community Medicine and Health and Outcomes Research, Saint Louis University School of Medicine, St. Louis, MO, USA.</aff><aff id="A8"><label>8</label>These authors contributed equally: Kevin Y. Xu, Tiffani D. M. Berkel.</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author contributions</p><p id="P2">Concept: K.Y.X., T.D.M.B., C.E.M. and R.A.G. Design: K.Y.X., T.D.M.B., C.E.M. and R.A.G. Analysis of data: K.Y.X. Interpretation of data: K.Y.X., T.D.M.B., C.E.M., H.E.J., E.B.C., J.C.K., C.M.M., F.R.L. and R.A.G. Drafting of manuscript: K.Y.X., T.D.M.B., C.E.M. and R.A.G. Obtained funding: R.A.G. Administrative, technical or material support: R.A.G. Critical revision for important intellectual content: K.Y.X., T.D.M.B., C.E.M., H.E.J., E.B.C., J.C.K., C.M.M., F.R.L. and R.A.G. Per Center for Administrative Data Research Data Use Agreement guidelines, K.Y.X. was the only individual who had access to the data and the only one to perform analyses. All the other authors did not have access to the data, although they contributed to the interpretation of data.</p></fn><corresp id="CR1"><label>&#9993;</label><bold>Correspondence and requests for materials</bold> should be addressed to Kevin Y. Xu. <email>xukeviny@wustl.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>11</day><month>6</month><year>2024</year></pub-date><volume>2</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">477713</issue-id><fpage>801</fpage><lpage>808</lpage><pub-history><event event-type="nihms-submitted"><date><day>19</day><month>06</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>26</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>26</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-28 23:25:14.587"><day>28</day><month>12</month><year>2024</year></date></event></pub-history><permissions><license><license-p><bold>Reprints and permissions information</bold> is available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/reprints">www.nature.com/reprints</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2002970.pdf"/><abstract id="ABS1"><p id="P3">While attention deficit hyperactivity disorder is common among people with addiction, the risks and benefits of attention deficit hyperactivity disorder medication in pregnant people with opioid use disorder are poorly understood. Here, using US multistate administrative data, we examined 3,247 pregnant people initiating opioid use disorder treatment, of whom 5% received psychostimulants. Compared to peers not receiving psychostimulants, the psychostimulant cohort had greater buprenorphine (adjusted relative risk 1.81 (1.50&#8211;2.18)) but lower methadone initiation (adjusted relative risk 0.39 (0.19&#8211;0.78)). Among psychostimulant recipients who initiated buprenorphine, we observed lower buprenorphine discontinuation associated with the psychostimulant cohort compared to nonrecipients (adjusted hazard ratio 0.77 (0.67&#8211;0.88)). In within-person case-crossover analyses, person-days defined by psychostimulant fills were associated with fewer substance use disorder-related admissions compared to days without fills (odds ratio 0.50 (0.33&#8211;0.76)). Overall, our data suggest that psychostimulant use in pregnancy may be associated with increased buprenorphine initiation, decreased methadone initiation and improved buprenorphine retention. Decreased substance use disorder-related admissions were associated with person-days of psychostimulant receipt, although other risks of psychostimulant use in pregnancy warrant further investigation.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>